Molecular Mechanism of TET-mediated Gene Regulation
TET介导的基因调控的分子机制
基本信息
- 批准号:10714155
- 负责人:
- 金额:$ 38.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:Aberrant DNA MethylationAcuteAnimal ModelBiological ProcessCell Differentiation processChromatinCytosineDNADNA MethylationDNA Modification ProcessDiseaseElementsEnhancersEnsureEnvironmentEnzymesEpigenetic ProcessFamilyGene ActivationGene ExpressionGene Expression RegulationGenesGenomic InstabilityGoalsHealthHematologic NeoplasmsHematopoietic NeoplasmsHistonesHumanImmunodeficiency and CancerLinkMaintenanceMalignant Childhood NeoplasmMalignant NeoplasmsMammalian CellMapsMediatingMethodsMethylationModificationMolecularMonitorMutateMutationResearchdemethylationepigenomeepigenome editinginsightmethylation patternmethylomenovelpermissivenessprogramstherapeutic target
项目摘要
PROJECT SUMMARY/ABSTRACT
DNA cytosine methylation is a central epigenetic modification in mammalian cells. Aberrant DNA methylation
has been linked to gene dysregulation and genomic instability, resulting in cancer and other diseases. Ten-
Eleven Translocation (TET) is the essential enzyme family responsible for DNA demethylation to ensure the
proper maintenance of the methylome. TET enzymes oxidize 5-methylcytosines (5mC) into mainly 5-
hydroxymethylcytosine (5hmC), an intermediate for DNA demethylation and a potential epigenetic mark.
Germline deficiency of TET2 is associated with immunodeficiency and childhood cancers. Notably, TET2 is
one of the most frequently mutated genes in hematological cancers, demonstrating the importance of TET in
multiple biological processes. We and others have shown that TET enzymes are essential for cell
differentiation by regulating super-enhancers and inducing the expression of lineage-specific genes. However,
the mechanism by which TET enzymes facilitate the permissive chromatin environment for gene activation
remains unclear. The long-term goals of the research program are: (1) to comprehensively understand how
TET enzymes and 5hmC promote chromatin accessibility; (2) to investigate the crosstalk between TET and
histones; (3) to understand the consequences of temporary perturbation of epigenome. To accomplish these
goals, we will use precision epigenome editing to manipulate and monitor epigenetic modifications of cis-
elements regulated by TET and DNA methylation. We will develop novel animal models to study the impact of
acute and reversible TET deficiency and a sequencing method to map multiple DNA modifications and
chromatin accessibility simultaneously on a single DNA molecule. Our research will provide crucial mechanistic
insights into how TET and DNA modifications regulate gene expression and cell differentiation. Our findings
will potentially identify genes involved in immunodeficiency and cancer, providing an opportunity to develop
targeted treatments.
项目摘要/摘要
DNA胞嘧啶甲基化是哺乳动物细胞的一种中心性表观遗传修饰。DNA甲基化异常
与基因失调和基因组不稳定有关,导致癌症和其他疾病。十个-
11易位(Tet)是负责DNA去甲基化的关键酶家族,以确保
适当地维护甲基组。Tet酶将5-甲基胞嘧啶(5mC)氧化成主要的5-甲基胞嘧啶
羟甲基胞嘧啶(5hmC),DNA去甲基化的中间体,也是潜在的表观遗传标记。
TET2的生殖系缺陷与免疫缺陷和儿童癌症有关。值得注意的是,TET2是
血液学癌症中最常见的突变基因之一,证明了Tet在
多个生物过程。我们和其他人已经证明了Tet酶对细胞是必不可少的
通过调节超级增强子和诱导谱系特异性基因的表达而发生分化。然而,
Tet酶促进基因激活的染色质环境的机制
目前仍不清楚。研究计划的长期目标是:(1)全面了解
Tet酶和5HmC促进染色质的可及性;(2)研究Tet和5HmC之间的串扰
组蛋白;(3)了解表观基因组暂时扰动的后果。要实现这些目标
目标,我们将使用精确的表观基因组编辑来操纵和监测顺式基因的表观遗传修饰。
受Tet和DNA甲基化调节的元件。我们将开发新的动物模型来研究
急性和可逆性Tet缺乏症和测序方法
染色质在单个DNA分子上同时可及。我们的研究将提供关键的机制
洞察Tet和DNA修饰如何调节基因表达和细胞分化。我们的发现
将可能识别与免疫缺陷和癌症有关的基因,提供一个发展的机会
有针对性的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chan-Wang Jerry Lio其他文献
Chan-Wang Jerry Lio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chan-Wang Jerry Lio', 18)}}的其他基金
TET-mediated Epigenetic Regulation in the Development and Immunoevasion of B cell Lymphoma
TET 介导的表观遗传调控 B 细胞淋巴瘤的发生和免疫逃避
- 批准号:
10242616 - 财政年份:2020
- 资助金额:
$ 38.36万 - 项目类别:
TET-mediated Epigenetic Regulation in the Development and Immunoevasion of B cell Lymphoma
TET 介导的表观遗传调控 B 细胞淋巴瘤的发生和免疫逃避
- 批准号:
10460237 - 财政年份:2020
- 资助金额:
$ 38.36万 - 项目类别:
相似海外基金
Research on the pathophysiology of acute transient psychosis using animal model
急性短暂性精神病动物模型病理生理学研究
- 批准号:
22K07589 - 财政年份:2022
- 资助金额:
$ 38.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A new monitoring method using transpulmonary thermodilution in an animal model of acute respiratory distress syndrome.
在急性呼吸窘迫综合征动物模型中使用经肺热稀释的新监测方法。
- 批准号:
21K16596 - 财政年份:2021
- 资助金额:
$ 38.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Testing existing and new therapeutic interventions in a novel animal model of acute Spot Positive intracranial hemorrhage
在急性斑点阳性颅内出血的新型动物模型中测试现有和新的治疗干预措施
- 批准号:
342058 - 财政年份:2016
- 资助金额:
$ 38.36万 - 项目类别:
Operating Grants
Development of a gene therapy approach to treat acute lung injury using a preclinical, large animal model
使用临床前大型动物模型开发治疗急性肺损伤的基因治疗方法
- 批准号:
9044084 - 财政年份:2016
- 资助金额:
$ 38.36万 - 项目类别:
Effect of Stem Cells derived from Human Exfoliated Decidious Teeth in animal model of acute liver failure-correlation between inflammation and regeneration in liver
人脱落乳牙干细胞在急性肝功能衰竭动物模型中的作用——肝脏炎症与再生的相关性
- 批准号:
15K08996 - 财政年份:2015
- 资助金额:
$ 38.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The search of the drug for the acute severe HBV hepatitis using animal model
动物模型寻找治疗急性重型乙型肝炎药物
- 批准号:
15K09003 - 财政年份:2015
- 资助金额:
$ 38.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A new animal model for stress-induced transition from acute to chronic pain
压力引起的急性疼痛向慢性疼痛转变的新动物模型
- 批准号:
9081225 - 财政年份:2014
- 资助金额:
$ 38.36万 - 项目类别:
A new animal model for stress-induced transition from acute to chronic pain
压力引起的急性疼痛向慢性疼痛转变的新动物模型
- 批准号:
8862455 - 财政年份:2014
- 资助金额:
$ 38.36万 - 项目类别:
Development of a animal model of acute encephalopathy and an antibody therapy
急性脑病动物模型的开发和抗体治疗
- 批准号:
26670500 - 财政年份:2014
- 资助金额:
$ 38.36万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
A new animal model for stress-induced transition from acute to chronic pain
压力引起的急性疼痛向慢性疼痛转变的新动物模型
- 批准号:
8976522 - 财政年份:2014
- 资助金额:
$ 38.36万 - 项目类别:














{{item.name}}会员




